Methuselah Medical Technology
Specializes in the design, development and manufacture of robust, rugged, and user-friendly volumetric intravenous
About Methuselah Medical Technology
Methuselah (Shanghai) Medical Technology Co., Ltd. is a medical nutrition company established in March 2012, operating from the International Medical Park in Shanghai, a hub for high-tech pharmaceutical enterprises. The firm integrates research and development, production, and sales, focusing on the specific nutritional needs of the Chinese population. To enhance its R&D capabilities, the company has formed a strategic alliance with a major U.S. medical food technology company and collaborates with various domestic clinical nutrition expert teams. It has also established academic partnerships with prominent institutions like the Chinese Nutrition Society and the Chinese Medical Association.
The company's business model is centered on developing and selling medical nutrition products directly to healthcare providers and patients, with its products being used in over 300 top-tier hospitals in China. Methuselah Medical Technology's product portfolio is organized into four main categories. The first is a line of special medical formula foods, featuring products named Youkangli and Youyili. The second category consists of nutritionally fortified foods such as Yusu and Yusu Peptide. A third series focuses on low-glycemic index (Low-GI) foods, including biscuits, noodles, and meal replacement powders. The final category includes energy-controlled and fat-controlled food series. The company operates two production bases, including one in Luohe, Henan, which specializes in low-GI foods.
Methuselah's establishment coincided with a significant shift in China's regulatory landscape for medical foods, positioning the company to capitalize on the growing market for special medical purpose formula foods. The company's name itself, referencing the biblical figure who lived for 969 years, reflects its mission to promote health and longevity through medical nutrition. Internally, Methuselah has assembled a professional R&D team comprising dozens of experts with titles as physicians, pharmacists, and nutritionists, which it considers a core component of its competitive strength.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Aug 2025 | $14M | $138M | Highlight Capital · Jiangsu Bailian Zhigao Venture Capital Management · Hongsheng Capital | ↗ |
| SERIES BOther financing | Feb 2025 | $28M | $110M | Shanghai CICC Capital · Frees Fund · Feng Qiao Capital · Highlight Capital | ↗ |
Growth signals
Latest recorded traffic for Methuselah Medical Technology is 170 monthly website visits, down 63% over the last three months. Methuselah Medical Technology's team grew 9.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Methuselah Medical Technology in its local ecosystem
The Methuselah Medical Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A7 investors entered at this stage
Frees Fund
Jinding Capital
Shanghai CICC Capital
Highlight Capital
Feng Qiao Capital- JMJiangsu Bailian Zhigao Venture Capital Management
- HCHongsheng Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Methuselah Medical Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Methuselah Medical Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









